Definitive Contract 75N93025C00032

Award Date 9/15/25
Potential Completion Date 9/14/28
Potential Value $1.5M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Frederick, MD 21702, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $299,937 firm fixed-price contract to Chromologic LLC, a minority-owned, for-profit limited liability company, for a Phase I Small Business Innovation Research (SBIR) project titled "CHROMOLOGIC." The contract supports research and development efforts for a "CRIPR-BASED ASSAY FOR PORTABLE TROPICAL INFECTION DIAGNOSIS (CAPTIN-D)." There is no set-aside designation for this contract. Chromologic has...
This is a Phase II SBIR contract award to Biological Mimetics, Inc., a biotechnology firm in Frederick, Maryland, by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency. The $1,498,641 Firm Fixed Price contract is for the development of a CRISPR-based diagnostic test for parasites, with a completion date of September 14, 2028. The contract is set aside for small businesses under the SBIR program, which aims to stimulate technological innovation. Biological...
This is a $299,820.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Biological Mimetics, Inc. for a Phase I Small Business Innovation Research (SBIR) project to develop a CRISPR-based diagnostic test for parasites. The contract is not set aside. Biological Mimetics is a biotechnology firm that conducts research and development on infectious diseases, vaccines, diagnostics, and...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract, valued at $224,997.00, was awarded to Chromologic LLC, a minority-owned, for-profit limited liability company, to conduct research and development for the BICER program. The contract has a Firm Fixed Price pricing type and a completion date of September 9, 2016....
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $299,993 Small Business Innovation Research (SBIR) Phase I contract to Chromologic LLC, a minority-owned and Asian-Indian American-owned limited liability company, for the development of "Mobile Health Point-of-Care Diagnostics for Malaria." This contract is focused on research and development of rapid diagnostic technologies for malaria, a...
This federal contract award, valued at $299,914.00, was granted to Chromologic LLC, a minority-owned, for-profit limited liability company, by the National Institute of Allergy and Infectious Diseases, a civilian agency. The contract, which is a Definitive Contract with a Firm Fixed Price pricing type, is for the SBIR 134 - CHROMOLOGIC project. The contract does not have a set-aside designation and has an ultimate completion date of September 24, 2025. Chromologic is a manufacturer of goods that...
This award is for a $1,074,903.98 Firm Fixed Price contract under the Defense Health Agency's (DHA) Small Business Innovation Research (SBIR) program. The contract was awarded to Chromologic LLC, a minority-owned small business, for the development of a Phase II project titled "In-Line, Non-Invasive, Non-Destructive Cell Monitoring in Dynamically Growing Cultures". The project was solicited under DHA SBIR Topic DHA18-006, and the work is to be performed in Monrovia, California....
Chromologic LLC, a minority-owned small business, has been awarded a definitive fixed-price contract valued at $1,498,121 by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. The contract is for the delivery of mobile health point-of-care diagnostics for malaria, to be performed in Monrovia, California, with work expected to be completed by January 2025. No set-aside designation was used for this award. Through...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government. The contract, with a ceiling value of $299,943.00, has been awarded to Lifetime Omics, Inc., a minority-owned, woman-owned, and small disadvantaged business. The contract is for research related to SBIR Topic 123, with a completion date of November 30, 2024. The contract is a definitive contract with a firm...
This is a $300,000 Firm Fixed Price contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Vitruvian Bio, LLC, a small disadvantaged woman-owned business. The contract is for a Small Business Innovation Research (SBIR) Phase I project to be completed by June 30, 2023. The award is associated with a larger SBIR solicitation that sought innovative research proposals from small businesses to...

This is a Phase II Small Business Innovation Research (SBIR) award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Chromologic LLC, a minority-owned small business headquartered in Monrovia, California. The award, valued at $1,499,763.00, is for the development of a CRISPR-based assay for portable tropical infection diagnosis (CAPTIN-D). This is a Firm Fixed Price definitive contract with a completion date of September 14, 2028. The award is designated as a total small business set-aside.

Generated 9/26/25, 10:04 AM